Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Entergy
ETR
|
+$79.1M |
| 2 |
DTE Energy
DTE
|
+$73.2M |
| 3 |
FedEx
FDX
|
+$48.6M |
| 4 |
Marathon Petroleum
MPC
|
+$47.5M |
| 5 |
CMS Energy
CMS
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$75.8M |
| 2 |
ExxonMobil
XOM
|
+$62M |
| 3 |
Linde
LIN
|
+$49.9M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$38.6M |
| 5 |
Expedia Group
EXPE
|
+$29.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.24% |
| 2 | Technology | 13.54% |
| 3 | Utilities | 9.55% |
| 4 | Financials | 8.68% |
| 5 | Healthcare | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Brinker International
EAT
$10.9B
| $484K | 0.01% |
21,960
-70,867
| -76% | -$2.24M |
|
1377
Euronet Worldwide
EEFT
$2.61B
| $484K | 0.01% |
4,811
-36,054
| -88% | -$4.27M |
|
|
GRCL
1378
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $481K | 0.01% |
+87,529
| New | +$272K |
|
1379
Crane NXT
CXT
$2.87B
| $480K | 0.01% |
+15,791
| New | +$525K |
|
1380
Edgewise Therapeutics
EWTX
$4.93B
| $478K | 0.01% |
+60,028
| New | +$454K |
|
1381
TORM
TRMD
$3.23B
| $475K | 0.01% |
+35,050
| New | +$412K |
|
1382
Paylocity
PCTY
$8.14B
| $474K | 0.01% |
2,715
-34,379
| -93% | -$6.27M |
|
1383
Ormat Technologies
ORA
$6.53B
| $472K | 0.01% |
6,020
-73,576
| -92% | -$5.8M |
|
1384
Coca-Cola Consolidated
COKE
$12.8B
| $471K | 0.01% |
+8,350
| New | +$436K |
|
1385
ASE Group
ASX
$96.1B
| $470K | 0.01% |
90,992
+27,267
| +43% | +$182K |
|
1386
AZZ Inc
AZZ
$4.23B
| $470K | 0.01% |
11,522
+1,121
| +11% | +$50.3K |
|
1387
Gold Fields
GFI
$42.5B
| $470K | 0.01% |
+51,554
| New | +$616K |
|
|
GOOD
1388
Gladstone Commercial Corp
GOOD
$634M
| $470K | 0.01% |
24,972
-21,985
| -47% | -$447K |
|
1389
Expro Ltd
XPRO
$2.02B
| $469K | 0.01% |
+40,704
| New | +$582K |
|
1390
Element Solutions
ESI
$8.53B
| $468K | 0.01% |
+26,315
| New | +$534K |
|
|
NAAC
1391
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
| $466K | 0.01% |
+47,340
| New | +$464K |
|
|
ATCO
1392
DELISTED
Atlas Corp.
ATCO
| $464K | 0.01% |
43,338
-72,300
| -63% | -$908K |
|
1393
Lam Research
LRCX
$390B
| $463K | 0.01% |
10,880
-32,360
| -75% | -$1.54M |
|
1394
GeoPark
GPRK
$625M
| $462K | 0.01% |
35,731
+23,493
| +192% | +$367K |
|
1395
Bank OZK
OZK
$5.37B
| $462K | 0.01% |
+12,312
| New | +$486K |
|
1396
Workhorse Group
WKHS
$35.1M
| $462K | 0.01% |
59
-48
| -45% | -$453K |
|
1397
MDU Resources
MDU
$4.21B
| $460K | 0.01% |
44,829
-735,337
| -94% | -$7.47M |
|
1398
Beyond Meat
BYND
$238M
| $458K | 0.01% |
638
-147
| -19% | -$141K |
|
|
TGNA
1399
DELISTED
TEGNA Inc
TGNA
| $458K | 0.01% |
21,849
-6,056
| -22% | -$131K |
|
1400
Corcept Therapeutics
CORT
$13.4B
| $457K | 0.01% |
19,210
-68,544
| -78% | -$1.49M |
|
Similar funds
Michael Gelband's Q2 2022 Portfolio in Review
As of Q2 2022, Michael Gelband held 2,786 positions worth $8.16B, up 3.1% from $7.91B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Michael Gelband deployed $1.5B of net new capital in Q2 2022, opening 644 new positions and adding to 646 existing holdings. Its largest new stake was Marathon Petroleum: 508,082 shares worth $41.8M.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was AT&T, an estimated $75.8M trimmed.
- Michael Gelband's largest Q2 2022 buy was Marathon Petroleum: 508,082 shares worth $41.8M.
- Michael Gelband added most to Entergy in Q2 2022, an estimated $79.1M increase.
- Michael Gelband's biggest Q2 2022 reduction was AT&T, cutting an estimated $75.8M.
- Michael Gelband fully exited Linde in Q2 2022, selling an estimated $49.9M.
- Michael Gelband's ten largest holdings make up 14% of its $8.16B portfolio in Q2 2022.
- Michael Gelband opened 644 new positions and closed 902 in Q2 2022.
- Michael Gelband's portfolio value rose 3.1% quarter-over-quarter to $8.16B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.